Oklo's regulatory pathway shifted after DOE Reactor Pilot Program selection, allowing construction to proceed while NRC commercial licensing continues in parallel. DOE approval of the Aurora fuel fabrication safety document enables assembly at Idaho National Laboratory, directly addressing nuclear fuel bottlenecks. Oklo's diversified fuel strategy spans government legacy fuel, enrichment partnerships, and a future Advanced Fuel Center, reducing Generation IV supply risks.
OKLO soared over 300% in 2025, but mounting risks from dilution and delays may test investor conviction.
Oklo (NYSE: OKLO) and NuScale Power (NYSE: SMR) both operate in the small modular reactor space, but their recent quarterly results reveal two companies at radically different stages.
OKLO's new $1.5B ATM program adds major financing flexibility as the company accelerates reactor deployment, fuel recycling, and isotope production.
The nuclear energy companies, which include the likes of reactor innovator Oklo (NASDAQ:OKLO) and Canadian uranium producer Cameco (NYSE:CCJ), have been a pretty popular way to bet on the great AI race without betting on the technological innovators themselves.
OKLO's volatile microreactor ambitions and D's steady nuclear backbone offer a stark contrast as both vie for a growing clean-power future.
OKLO jumps as its binding Siemens Energy deal pushes the Aurora project into construction and cuts major supply-chain risk.
Welcome to the Green Stock News brief for Wednesday November 19th. Here are today's top headlines: Oklo (NYSE: OKLO) and Siemens Energy signed a binding contract for Siemens to design and deliver the power conversion system for Oklo's first Aurora advanced fission reactor.
OKLO's latest quarterly miss and a sharp stock slide raise fresh questions about its valuation and near-term outlook.
Oklo ( NYSE:OKLO ) has drawn investor attention as a leading player in advanced nuclear technology.
Investors can expect Oklo's NYSE: OKLO volatility to continue for the foreseeable future, but the bottom is in for this market, and a robust rebound is brewing. Forces, including the company's operations, institutional activity, analyst trends, and short interest, are aligning and need only a catalyst to ignite the movement.
Oklo (NYSE:OKLO) is positioned for growth in the US nuclear sector, according to Wedbush analysts, who maintained an ‘Outperform' rating with a 12-month price target of $150 after the pre-commercialization nuclear firm reported its Q3 financial results. Shares of Oklo traded up 8.3% post-earnings at $113.